Company profile

Sunho Biologics

2898 · HKEX (Two rows for one company: the CT.gov sponsor string 'SUNHO（China）BioPharmaceutical CO., Ltd.' (with full-width brackets) and the listed name 'Sunho Biologics'. Both are HKEX 2898. Duplicate company row 1228 ("SUNHO（China）BioPharmaceutical CO., Ltd.") merged into this one on 2026-08-05; source: https://finance.yahoo.com/quote/2898.HK/)

Public Market Listing

2898HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Sunho Biologics are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
IAP0971
Phase 2
PD-1 x IL-15/IL-15Rα complexSmall molecule
Non-Small Cell Lung Cancer
ISH0688
Phase 1
FGF21 receptor
Atherosclerotic Cardiovascular Disease

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.